These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24836527)

  • 1. Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population.
    Mulhern B; Rowen D; Snape D; Jacoby A; Marson T; Hughes D; Baker G; Brazier J
    Epilepsy Behav; 2014 Jul; 36():12-7. PubMed ID: 24836527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.
    Mulhern B; Pink J; Rowen D; Borghs S; Butt T; Hughes D; Marson A; Brazier J
    Value Health; 2017 Apr; 20(4):687-693. PubMed ID: 28408012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a QALY measure for epilepsy: NEWQOL-6D.
    Mulhern B; Rowen D; Jacoby A; Marson T; Snape D; Hughes D; Latimer N; Baker GA; Brazier JE
    Epilepsy Behav; 2012 May; 24(1):36-43. PubMed ID: 22503427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian population-based values of EQ-5D health states.
    Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
    Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the SF-6D value set for a population-based sample of Brazilians.
    Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of social care for adults: developing a preference-weighted measure.
    Netten A; Burge P; Malley J; Potoglou D; Towers AM; Brazier J; Flynn T; Forder J; Wall B
    Health Technol Assess; 2012; 16(16):1-166. PubMed ID: 22459668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).
    Goodwin E; Green C; Hawton A
    Value Health; 2018 Nov; 21(11):1338-1345. PubMed ID: 30442282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population.
    Ratcliffe J; Stevens K; Flynn T; Brazier J; Sawyer MG
    Value Health; 2012; 15(5):730-6. PubMed ID: 22867783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis.
    Goodwin E; Green C; Hawton A
    Value Health; 2020 Feb; 23(2):242-250. PubMed ID: 32113630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse probability weighted estimation of social tariffs: an illustration using the SF-6D value sets.
    Méndez I; Abellán Perpiñán JM; Sánchez Martínez FI; Martínez Pérez JE
    J Health Econ; 2011 Dec; 30(6):1280-92. PubMed ID: 21920617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Portuguese value set for the SF-6D.
    Ferreira LN; Ferreira PL; Pereira LN; Brazier J; Rowen D
    Value Health; 2010 Aug; 13(5):624-30. PubMed ID: 20230545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DEP-6D, a new preference-based measure to assess health states of dependency.
    Rodríguez-Míguez E; Abellán-Perpiñán JM; Alvarez XC; González XM; Sampayo AR
    Soc Sci Med; 2016 Mar; 153():210-9. PubMed ID: 26921836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trade-off derived EQ-5D weights for Australia.
    Viney R; Norman R; King MT; Cronin P; Street DJ; Knox S; Ratcliffe J
    Value Health; 2011; 14(6):928-36. PubMed ID: 21914515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-retest reliability of health state valuation techniques: the time trade off and person trade off.
    Robinson S
    Health Econ; 2011 Nov; 20(11):1379-91. PubMed ID: 21053203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Portuguese and UK health state values differ across valuation methods?
    Ferreira LN; Ferreira PL; Rowen D; Brazier JE
    Qual Life Res; 2011 May; 20(4):609-19. PubMed ID: 21061071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.